Fluoropyrimidines are widely used for the treatment of various solid tumors. The PGX-5FU StripAssay® identifies the most severe genetic variant in the dihydropyrimidine dehydrogenase (DPYD) gene whereas the newly launched PGX-5FU XLStripAssay® covers the four most clinically important variants with therapeutic relevance for fluoropyrimidine treatment as recommended by the European Medicines Agency in April 2020.
Link to CPIC Guidelines
Product | REF | Unit Size | IFU | Brochure |
---|---|---|---|---|
PGX-5FU StripAssay® | 4-720 | 20 tests | ||
PGX-5FU XL StripAssay® | 4-780 | 20 tests |
SouthernBiotech/Goat Anti-Human Lambda-Alexa Fluor® 555/2070-32/1.0 mg
vectorlabs/Biotinylated Aleuria Aurantia Lectin (AAL)/B-1395/1 mg
vectorlabs/VECTASTAIN® Elite® ABC-HRP Kit (Peroxidase, Mouse IgG)/PK-6102/1 kit
vectorlabs/VECTASTAIN® Elite® ABC-HRP Kit (Peroxidase, Universal)/PK-6200/1 kit
vectorlabs/Unconjugated Musa Paradisiaca (Banana) Lectin (BanLec)/L-1410/5 mg
GiottoBiotech/Calmodulin N60D/5 mg/G02CLM60cn